Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Articles & videos

All years
  • 2022
  • 2021
  • 2020
  • 2019
Videos
  • Media
  • Videos
  • All categories
nanoform-6
November 2, 2022

Video : CPHI Frankfurt with Life Sciences Knowledge Hub

Our commercial team gathered in Frankfurt for CPHI! Check out the video to learn more about our sustainability initiatives, our exciting collaboration with TargTex and our game-changing STARMAP® Online technology – a finalist for the CPHI awards. 
Learn more
October 25, 2022

PODD 2022 – How drug delivery is enabling a clinical trial for Glioblastoma

TargTex CEO Dr João Seixas and Nanoform CCO Christian Jones presented highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM), at the PODD Conference (Partnerships and Opportunities in Drug Delivery), in Boston USA.

Video
nanoform-1
October 14, 2022

Video : ADHD Awareness Month – how can STARMAP® Online guide the way?

In recognition of ADHD Awareness Month, we want to draw your attention to our innovative nanoparticle technology and the value it can bring to molecules in development or products on the market for neurological disorders such as ADHD. Watch the video to learn more about our novel technology from our European Business Development Manager, Hui Yi Tee.
Learn more
nanoform-5
September 30, 2022

Video : World Alzheimer’s Month – how can the power of innovative nanoparticle engineering make the difference?

As World Alzheimer’s Month comes to a close, we are thinking about how we at Nanoform can facilitate the next wave of novel medicines for this debilitating disease. Check out our video below to hear our Commercial Insights Officer, Jamie Unwin, discuss the power of our innovative nanoparticle engineering technology and AI-based digital twin.

Learn more
999999999.20220506094245970.9
May 6, 2022

Nanoform’s collaboration with TargTex

TargTex CEO João Seixas discusses the value Nanoform’s CESS technology delivered for TargTex’s novel drug candidate targeting glioblastoma, one of the most common and aggressive types of primary brain tumor. The partnership with Nanoform was critical in achieving success at this stage, with hope the product can now be taken further into clinical development.

Learn more
November 26, 2021

Pharma Integrates 2021

Video 1: “Are you in or out?” panel discussion at Pharma Integrates 2021

Our VP of Business Development, Nathalie Huther, PhD, MRSC, shared her insights into how the pandemic has affected pharma outsourcing and what it means for the future at Pharma Integrates 2021.

Video 2: ’Forecasting Pharma’s Future” panel discussion at Pharma Integrates 2021

Our Commercial Insight Officer, Jamie Unwin, shared his perspective on the future of Pharma and patient-centric technological innovation at Pharma Integrates 2021.

Video 1 Video 2
November 26, 2021

Partnerships in Drug Delivery (PODD) 2021

Video 1: Nanotechnology Fireside Chat at Partnerships in Drug Delivery (PODD) 2021

Our CEO, Prof. Edward Hæggström, was delighted to join a fireside chat at PODD with Shawn Davies, Head of Drug Delivery, Biopharmaceuticals Development, AstraZeneca – a long term partner of Nanoform – to discuss the potential of nanoscale medicines and delivery devices to benefit patients.

Video 2: “Small is transformative: nanoparticle solutions for drug delivery innovation” at Partnerships in Drug Delivery (PODD) 2021

Our VP of US Business Development, Eric Peter, delved into the human trial results for the world’s first nanoformed drug at PODD 2021. He also discussed the ongoing industry collaborations investigating how nanoparticle engineering can facilitate drug delivery innovation to ultimately benefit patients.

Video 1 Video 2
November 17, 2021

Video: BIO-Europe 2021 fireside chat

Our Commercial Insights Officer, Jamie Unwin, sat down with Tim Pang, Executive Director, Pharma Consulting at Informa Pharma Custom Intelligence, at BIO-Europe 2021 for a fireside chat “(b)(2) or not to be – understanding the commercial returns possible from patient-centric differentiation strategies through the 505(b)(2) pathway.”
Learn more
November 16, 2021

Webinar: Tailored API Nanoparticles: How Powerful Can Small Be?

Our VP of US Business Development, Chris Worrall, hosted a webinar “Tailored API Nanoparticles: How Powerful Can Small Be?” in partnership with the American Association of Pharmaceutical Scientists (AAPS). Tune in to discover the benefits of tailoring nanoparticles for the development of patient-centric medicines.

Learn more
PharmSci NANO
November 2, 2021

Poster presentation : ‘’Small is powerful : Comparison of approaches to tackle poor solubility of drugs’’ at AAPS PharmSci 360 2021

Nanoform Director of Pharmaceutical Development, Satu Lakio, presented a poster to AAPS on the effectiveness of Nanoformed particles compared clinically against two commercially approved products.

Learn more
PharmSci NANO
October 22, 2021

Video presentation: Demonstrating the Power of Controlled-Expansion scCO2 Applied to Drug Development at AAPS PharmSci 360 2021

Watch Nanoform Director of Pharmaceutical Development, Satu Lakio, present to AAPS how effective Nanoformed particles could be when compared clinically against two commercially approved products.

Learn more
October 15, 2021

“Nanoformers, Particles in Disguise! – Illuminating the future of Pharma with STARMAP®.” PharmaTech Integrates 2021

Nanoform were attendees at Life Science Integrates’ and the Medicines Manufacturing Innovation Centre’s one-day event, PharmaTech Integrates. Science & Technology Team Leader, Elisabetta Micelotta, hosted the technical showcase “Nanoformers, Particles in Disguise! – Illuminating the future of Pharma with STARMAP®.” In this session, she discussed the power of AI for streamlining drug development.
Learn more
999999999.20211008151441206.999999999.20211008151441206qxaau
October 8, 2021

“Revolution not evolution of Biologics production” PharmaTech Integrates 2021

Nanoform were attendees at Life Science Integrates’ and the Medicines Manufacturing Innovation Centre’s one-day event, PharmaTech Integrates. Our Commercial Insights Officer, Jamie Unwin shared his thoughts on the “Revolution not evolution of Biologics production” panel. The session explored how the industry can step up to meet patient need and market demand by streamlining, enhancing and integrating upstream and downstream biological and vaccine production.

Learn more
nanoform-6
September 23, 2021

Applying AI and our innovative nanoforming technologies to achieve our patient-centric ambitions

David McCelland from Life Science Knowledge Hub interviews Jamie Unwin, our Commercial Insights Officer at Nanoform. They discuss Nanoform’s growth and their ambition of touching the lives of billion patients. Jamie also emphasises the importance of their data-driven approach and how AI is transforming the approach to drug development.

Learn more
nanoform-2
September 13, 2021

“Preparing for Patient-Centric Drug Development Regulations” American DDF Summit 2021

The Nanoform team attended the American DDF Summit (Drug Delivery & Formulation) with Commercial Insights Officer Jamie Unwin chairing a panel discussion titled “Preparing for Patient-Centric Drug Development Regulations”. The session explored the topic of patient centric drug design and how patient centricity can influence the drug development process.

Learn more
June 11, 2021

Nanoform’s transformation a year on from the IPO

A year on from Nanoform’s IPO in June 2020, we have made trailblazing progress. In this video, we share how we’ve transformed to reach key milestones, from the launch of our biologics technology to the completion of our first-in-human trial of a nanoformed drug candidate.

Learn more
June 3, 2021

Video: CPhI Discover 2021 presentation

We were pleased to host a session, “Overcoming Drug Development Challenges with Nanotechnology,” at the first ever CPhI Discover virtual event. Nanoform CCO Christian Jones, FRSC, Nanoform Science & Technology Team Leader Elisabetta Micelotta, and experts from Johnson Matthey and Quotient Sciences shared insights into the power of sparse-data AI in drug development and the collaborative studies investigating the performance of our CESS® technology.

Watch it here to learn more about AI-guided nanoparticle engineering in Pharma, from early drug development to clinic.

Learn more
May 20, 2021

Video: Bio Integrates 2021 panel discussion

Our CCO, Christian Jones, FRSC, joined the Bio Integrates panel discussion “Start with an end in mind” on Thursday, May 20th, 2021. The panel explored the importance of connecting with patients to make sure that  products are designed around the patient’s needs.



Learn more
nanoform-the-nanomed-zone-image
May 12, 2021

Video: The Nanomed Zone webinar

We were excited to showcase the results from our collaboration with Johnson Matthey in our webinar with The Nanomed Zone: “How CESS® technology stacks up against the competition: the smaller, the better!”.

Watch the presentation to learn how CESS® nanoparticles of a model compound have been found to exhibit improved dissolution performance relative to all other industry standard approaches tested, including spray drying.



Learn more
April 16, 2021

12th Global DDF Summit

Our Director of Pharmaceutical Development, Satu Lakio, gave a presentation at the 12th Global DDF Summit (Drug Delivery & Formulation) covering “Unique Nanoforming Technology for Poorly Soluble APIs by Nanoform”.

Learn more
nanoform-bio-europe-spring-featured
March 30, 2021

Video: Bio-Europe panel discussion

Our Head of AI, Prof. Jukka Corander joined a panel discussion at BIO-Europe Spring 2021 on “Big data & AI: applications in the real world”. Watch the video to find out out how Sparse Data AI & specifically STARMAP® can transform healthcare.

Learn more
January 13, 2021

Video: Nanoform 2020 in review

We achieved a number of milestones in 2020, check out the highlights here!

Learn more
December 21, 2020

Video: The first ever human trial of a nanoformed drug

In partnership with Quotient Sciences, the healthy volunteers have been successfully dosed in the first ever phase 1 human trial of a nanoformed drug candidate.

Learn more
December 17, 2020

Video: Advancements with Ted Danson

Hosted by Ted Danson, this episode of Advancements aimed to enlighten the public on how Nanoform’s award-winning CESS® nanoparticle engineering technology can potentially double the number of drug candidates progressing into clinic, open up new drug delivery routes and improve the lives of patients worldwide.

Learn more
November 23, 2020

Video: Nanoform’s virtual tours

Join a virtual tour of our Helsinki facility to meet our experts, get up close to our award-winning technology, and even participate in real-time questions and discussions.

Learn more
October 26, 2020

Amplifying Scientific Innovation Podcast

Our CCO, Christian Jones, joins Dr. Sophia Ononye-Onyia on the Amplifying Scientific Innovation podcast to discuss his outlook on the life science industry and Nanoform’s unique focus on nanotechnology innovation.

Learn more
March 26, 2020

DDF Summit Presentation

Our CCO, Christian Jones, shares his thoughts at the DDF Summit on how our award-winning CESS® technology can change the future of medicine.

Learn more
January 6, 2020

Our CCO, Christian Jones, talks to The Medicine Maker at CPhI Worldwide 2019

Our CCO, Christian Jones, joins The Medicine Maker to discuss the challenges that the drug discovery and development market face today, and how our nanoforming technology can help solve these issues and drive pharmaceutical efficiency.

Learn more
February 22, 2019

Contract Pharma

Our CTO, Niklas Sandler, and Head of AI, Jukka Corander, were interviewed by Contract Pharma to discuss the application of AI for enhanced drug particle engineering.

At the Bio-Europe Spring meeting, our CCO, Christian Jones, discusses how we use physics to enhance drug discovery and development for our partners in the pharmaceutical industry.

Learn more

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8